Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
10.95Price to Free Cash Flow
VS
Market
Sector
Industry
History
$ 10.05Close
$ 3.7 - $ 11.11 52-Week Range
Ticker Information
Ticker
GLUECompany Name
MONTE ROSA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMONTE ROSA THERAPEUTICS INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GLUE - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 23.85M | $ 261.24M | 10.95 |
| 3/31/2025 | $ 30.48M | $ 259.57M | 8.52 |
| 12/31/2024 | $ 38.01M | $ 434.26M | 11.43 |
| 9/30/2024 | $ -62.79M | $ 585.49M | 0 |
| 6/30/2024 | $ -67.76M | $ 244.26M | 0 |
| 3/31/2024 | $ -69.74M | $ 261.65M | 0 |
| 12/31/2023 | $ -62.78M | $ 305.44M | 0 |
| 9/30/2023 | $ -121.96M | $ 165.27M | 0 |
| 6/30/2023 | $ -117.61M | $ 331.72M | 0 |
| 3/31/2023 | $ -108.89M | $ 288.89M | 0 |
Key Performance Insights, Last 5 Years
- MONTE ROSA THERAPEUTICS INC's latest trailing twelve months (TTM) P/FCF stands at 0.
- Over the past 5 years, MONTE ROSA THERAPEUTICS INC's average P/FCF has been 10.3.
- The median P/FCF for MONTE ROSA THERAPEUTICS INC during this period was 10.95
- MONTE ROSA THERAPEUTICS INC reached its highest P/FCF over the past 5 years at 11.43.
- The lowest P/FCF recorded by MONTE ROSA THERAPEUTICS INC in the same timeframe 8.52
MONTE ROSA THERAPEUTICS INC's P/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/FCF Benchmarks
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for MONTE ROSA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 0 ] / FCF [ $ -26.44M ]
(=) P/FCF [ 0 ] GLUE - Price to Free Cash Flow, Last 5 years
8.52
Minimum
Mar 31, 2025
11.43
Maximum
Dec 31, 2024
10.3
Average
10.95
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.31 with a standard deviation of 12.92.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 60.45 |
| average | 18.31 |
| median | 14.73 |
| std | 12.92 |